SONOlysis in prevention of Brain InfaRctions During Internal carotid Endarterectomy (SONOBIRDIE) trial - study protocol for a randomized controlled trial

Tomáš Hrbáč, David Netuka, Vladimír Beneš, Vladimír Nosáľ, Petra Kešnerová, Aleš Tomek, Táňa Fadrná, Vladimír Beneš Jr, Jiří Fiedler, Vladimír Přibáň, Miroslav Brozman, Kateřina Langová, Roman Herzig, David Školoudík, Tomáš Hrbáč, David Netuka, Vladimír Beneš, Vladimír Nosáľ, Petra Kešnerová, Aleš Tomek, Táňa Fadrná, Vladimír Beneš Jr, Jiří Fiedler, Vladimír Přibáň, Miroslav Brozman, Kateřina Langová, Roman Herzig, David Školoudík

Abstract

Background: Carotid endarterectomy (CEA) is a beneficial procedure for selected patients with an internal carotid artery (ICA) stenosis. Surgical risk of CEA varies from between 2 and 15%. The aim of the study is to demonstrate the safety and effectiveness of sonolysis (continual transcranial Doppler monitoring, TCD) using a 2-MHz diagnostic probe with maximal diagnostic energy on the reduction of the incidence of stroke, transient ischemic attack (TIA) and brain infarction detected using magnetic resonance imaging (MRI) by the activation of the endogenous fibrinolytic system during CEA.

Methods/design: Design: a multicenter, randomized, double-blind, sham-controlled trial.

Scope: international, multicenter trial for patients with at least 70% symptomatic or asymptomatic ICA stenosis undergoing CEA.

Inclusion criteria: patients with symptomatic or asymptomatic ICA stenosis of at least 70% are candidates for CEA; a sufficient temporal bone window for TCD; aged 40-85 years, functionally independent; provision of signed informed consent. Randomization: consecutive patients will be assigned to the sonolysis or control (sham procedure) group by computer-generated 1:1 randomization. Prestudy calculations showed that a minimum of 704 patients in each group is needed to reach a significant difference with an alpha value of 0.05 (two-tailed) and a beta value of 0.8 assuming that 10% would be lost to follow-up or refuse to participate in the study (estimated 39 endpoints).

Endpoints: the primary endpoint is the incidence of stroke or TIA during 30 days after CEA and the incidence of new ischemic lesions on brain MRI performed 24 h after CEA in the sonolysis and control groups. Secondary endpoints are occurrence of death, any stroke, or myocardial infarction within 30 days, changes in cognitive functions 1 year post procedure related to pretreatment scores, and number of new lesions and occurrence of new lesions ≥0.5 mL on post-procedural brain MRI.

Analysis: descriptive statistics and linear/logistic multiple regression models will be performed. Clinical relevance will be measured as relative risk reduction, absolute risk reduction and the number needed to treat.

Discussion: Reduction of the periprocedural complications of CEA using sonolysis as a widely available and cheap method may significantly increase the safety of CEA and extend the indication criteria for CEA.

Trial registration: ClinicalTrials.gov, NCT02398734 . Registered on 20 March 2015.

Keywords: Brain infarction; Carotid; Endarterectomy; Sonolysis; Stroke.

References

    1. Tegos TJ, Kalodiki E, Nicolaides AN. Stroke: pathogenesis, investigations, and prognosis—Part II of III. Angiology. 2000;51(12):977–84. doi: 10.1177/000331970005101201.
    1. ÚZIS . Dying in Czech Republic in the year 2012. Praha: ÚZIS; 2013.
    1. Kalvach P. Mozkové ischémie a hemoragie. 3. Praha: Grada; 2010.
    1. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445–53. doi: 10.1056/NEJM199108153250701.
    1. Rothwell PM, Gutnikov SA, Warlow CP, European Carotid Surgery Trialists’ Collaboration Reanalysis of the final results of the European Carotid Surgery Trial. Stroke. 2003;34(2):514–23. doi: 10.1161/01.STR.0000054671.71777.C7.
    1. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–8. doi: 10.1001/jama.1995.03520420037035.
    1. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. Stroke. 2011;42(8):e420–63. doi: 10.1161/STR.0b013e3182112d08.
    1. AbuRahma AF, Hannay RS. A study of 510 carotid endarterectomies and a review of the recent carotid endarterectomy trials. W V Med J. 2001;97(4):197–200.
    1. Heyer EJ, Sharma R, Rampersad A, Winfree CJ, Mack WJ, Solomon RA, et al. A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol. 2002;59(2):217–22. doi: 10.1001/archneur.59.2.217.
    1. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 2001;104(17):1999–2002. doi: 10.1161/hc4201.099224.
    1. Kuliha M, Roubec M, Procházka V, Jonszta T, Hrbáč T, Havelka J, et al. Randomized clinical trial comparing neurological outcomes after carotid endarterectomy or stenting. Br J Surg. 2015;102(3):194–201. doi: 10.1002/bjs.9677.
    1. Akiyama M, Ishibashi T, Yamada T, Furuhata H. Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery. 1998;43(4):828–32. doi: 10.1097/00006123-199810000-00062.
    1. Behrens S, Daffertshofer M, Spiegel D, Hennerici M. Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull. Ultrasound Med Biol. 1999;25(2):269–73. doi: 10.1016/S0301-5629(98)00158-6.
    1. Daffertshoffer M, Fatar M. Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur J Ultrasound. 2002;16(1–2):121–30. doi: 10.1016/S0929-8266(02)00049-6.
    1. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke. 2000;31(3):610–4. doi: 10.1161/01.STR.31.3.610.
    1. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC, CLOTBUST Investigators Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging. 2004;14(2):113–7. doi: 10.1111/j.1552-6569.2004.tb00226.x.
    1. Eggers J, Seidel G, Koch B, König IR. Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA. Neurology. 2005;64(6):1052–4. doi: 10.1212/01.WNL.0000154599.45969.D6.
    1. Skoloudik D, Bar M, Skoda O, Vaclavik D, Hradilek P, Allendoerfer J, et al. Safety and efficacy of the sonographic acceleration of the middle cerebral artery recanalization: results of the pilot thrombotripsy study. Ultrasound Med Biol. 2008;34(11):1775–82. doi: 10.1016/j.ultrasmedbio.2008.04.002.
    1. Bardoň P, Kuliha M, Herzig R, Šaňák D, Langová K, Kaňovský P, et al. Changes in middle cerebral artery blood flow velocity during sonolysis using a diagnostic transcranial probe with a 2-MHz Doppler frequency in healthy volunteers. J Ultrasound Med. 2012;31(11):1789–94. doi: 10.7863/jum.2012.31.11.1789.
    1. Saqqur M, Tsivgoulis G, Nicoli F, Skoloudik D, Sharma VK, Larrue V, et al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging. 2014;24(3):209–20. doi: 10.1111/jon.12026.
    1. Školoudík D, Fadrná T, Bar M, Zapletalová O, Zapletal O, Blatný J, et al. Changes in haemocoagulation in healthy volunteers after a 1-hour thrombotripsy using a diagnostic 2–4 MHz transcranial probe. J Thromb Thrombolysis. 2008;26(2):119–24. doi: 10.1007/s11239-007-0079-8.
    1. Školoudík D, Kuliha M, Hrbáč T, Jonszta T, Herzig R, SONOBUSTER Trial Group Sonolysis in Prevention of Brain Infarction during Carotid Endarterectomy and Stenting (SONOBUSTER): a randomized, controlled trial. Eur Heart J. 2016;37(40):3096–102. doi: 10.1093/eurheartj/ehv492.
    1. Kincaid MS. Transcranial Doppler ultrasonography: a diagnostic tool of increasing utility. Curr Opin Anaesthesiol. 2008;21(5):552–9. doi: 10.1097/ACO.0b013e32830edc0b.
    1. Škoda O, Herzig R, Mikulík R, Neumann J, Václavík D, Bar M, et al. Clinical guideline for the diagnostics and treatment of patients with ischemic stroke and transitory ischemic attack – version 2016. Cesk Slov Neurol N. 2016;79(3):351–63.
    1. Flach HZ, Ouhlous M, Hendriks JM, Van Sambeek MR, Veenland JF, Koudstaal PJ, et al. Cerebral ischemia after carotid intervention. J Endovasc Ther. 2004;11(3):251–7. doi: 10.1583/03-1128.1.
    1. Lacroix V, Hammer F, Astarci P, Duprez T, Grandin C, Cosnard G, et al. Ischemic cerebral lesions after carotid surgery and carotid stenting. Eur J Vasc Endovasc Surg. 2007;33(4):430–5. doi: 10.1016/j.ejvs.2006.11.012.
    1. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ, ICSS-MRI Study Group et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS) Lancet Neurol. 2010;9(4):353–62. doi: 10.1016/S1474-4422(10)70057-0.
    1. Schnaudigel S, Gröschel K, Pilgram SM, Kastrup A. New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke. 2008;39(6):1911–9. doi: 10.1161/STROKEAHA.107.500603.
    1. Skoloudík D, Hurtíková E, Brát R, Herzig R, for the SONORESCUE Trial Group Sonolysis in Prevention of Brain Infarction during Cardiac Surgery (SONORESCUE): randomized, controlled trial. Medicine (Baltimore) 2016;95(20):e3615. doi: 10.1097/MD.0000000000003615.
    1. Aboyans V, De Carlo M, Kownator S, Mazzolai L, Meneveau N, Ricco JB, ESC Working Group on Peripheral Circulation et al. The year in cardiology 2015: peripheral circulation. Eur Heart J. 2016;37(8):676–85. doi: 10.1093/eurheartj/ehv709.
    1. Ricci S, Dinia L, Del Sette M, Anzola P, Mazzoli T, Cenciarelli S, et al. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2012;10:CD008348.
    1. Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke. 2010;41(2):280–7. doi: 10.1161/STROKEAHA.109.563304.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する